ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE…
HOUSTON, Jan. 26, 2025 (GLOBE NEWSWIRE) -- Radix, a global technology solutions company at the forefront of industrial digital transformation,…
December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest…